|
HY-116699-10mg
|
MedChemexpress LLC
|
CP-868388 (free base) [CAS 702681-67-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-116699-100mg
|
MedChemexpress LLC
|
CP-868388 (free base) [CAS 702681-67-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-116699-25mg
|
MedChemexpress LLC
|
CP-868388 (free base) [CAS 702681-67-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-116699-5mg
|
MedChemexpress LLC
|
CP-868388 (free base) [CAS 702681-67-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-116699-50mg
|
MedChemexpress LLC
|
CP-868388 (free base) [CAS 702681-67-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-129047B-100mL
|
MedChemexpress LLC
|
Recombinant Trypsin Solution [CAS 9002-07-7]
|
|
|
|
|
HY-14363-1mg
|
MedChemexpress LLC
|
TUG-424 [CAS 1082058-99-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14363-5mg
|
MedChemexpress LLC
|
TUG-424 [CAS 1082058-99-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-147351-10mg
|
MedChemexpress LLC
|
GPR40 agonist 6 [CAS 1798751-25-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-147351-100mg
|
MedChemexpress LLC
|
GPR40 agonist 6 [CAS 1798751-25-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-147351-25mg
|
MedChemexpress LLC
|
GPR40 agonist 6 [CAS 1798751-25-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-147351-5mg
|
MedChemexpress LLC
|
GPR40 agonist 6 [CAS 1798751-25-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-147351-50mg
|
MedChemexpress LLC
|
GPR40 agonist 6 [CAS 1798751-25-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-148418-1mg
|
MedChemexpress LLC
|
TUG-499 [CAS 1206629-08-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-14905-100mg
|
MedChemexpress LLC
|
Uridine triacetate [CAS 4105-38-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-151827-10mg
|
MedChemexpress LLC
|
DBCO-PEG2-NHS ester [CAS 2585653-12-7]
|
|
Cancer-programmed cell death
|
|
|
HY-151827-25mg
|
MedChemexpress LLC
|
DBCO-PEG2-NHS ester [CAS 2585653-12-7]
|
|
Cancer-programmed cell death
|
|
|
HY-151827-5mg
|
MedChemexpress LLC
|
DBCO-PEG2-NHS ester [CAS 2585653-12-7]
|
|
Cancer-programmed cell death
|
|
|
HY-151827-50mg
|
MedChemexpress LLC
|
DBCO-PEG2-NHS ester [CAS 2585653-12-7]
|
|
Cancer-programmed cell death
|
|
|
HY-151835-10mg
|
MedChemexpress LLC
|
DBCO-PEG24-NHS ester [CAS 2765066-38-2]
|
|
|
|
|
HY-151835-25mg
|
MedChemexpress LLC
|
DBCO-PEG24-NHS ester [CAS 2765066-38-2]
|
|
|
|
|
HY-151835-5mg
|
MedChemexpress LLC
|
DBCO-PEG24-NHS ester [CAS 2765066-38-2]
|
|
|
|
|
HY-154487-100mg
|
MedChemexpress LLC
|
Glycerol dioleate [CAS 25637-84-7]
|
|
|
|
|
HY-154487-50mg
|
MedChemexpress LLC
|
Glycerol dioleate [CAS 25637-84-7]
|
|
|
|
|
HY-16040-10mg
|
MedChemexpress LLC
|
AM095 (free acid) [CAS 1228690-36-5]
|
|
COVID-19-immunoregulation
|
|
